Dr. Evelegh received his PhD, Immunology from McMaster University and his BSc, Biology, from Laurentian University. His research
interests include regulatory and clinical management of medical devices to obtain clearance from regulatory bodies as well as the
development of novel technologies applicable to in vitro diagnostics.
Dr. Evelegh is one of the co-developers of the PreVu Non-Invasive
Skin Cholesterol Test technology and a former Vice President, Clinical and Regulatory Affairs at PreMD Inc., the company that formerly
owned PreVu. Dr. Evelegh and his colleagues at The Cleveland Clinic Foundation studied the ground-breaking relationship between Skin
Cholesterol and a positive stress test (Clinical Chemistry 47, No. 7, 2001). The data revealed a strong correlation between elevated
levels of Skin Cholesterol and abnormal treadmill stress-test results related to establishing risk for coronary artery disease. As
Vice President, Product Development Dr. Evelegh is involved in overseeing all aspects of PreVu technology advancement and testing,
including the development of new product platforms.
Dr. Evelegh also continues to serve as an Assistant Professor at the Department
of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University (part-time). He has over 20 years of experience
in researching and developing human diagnostics, including product development, clinical trials, regulatory submissions and
Dr. Horsewood received his PhD, Organic Chemistry, from Loughborough University of Technology, 1972. His research interests include the development of non-invasive diagnostic assays; production and characterization of monoclonal antibodies; development of immunoassay and immunodiagnostic methods; immunochemical methods of analysis; mechanisms of thrombocytopenias and the role of specific platelet molecules in hemostasis; mechanisms of platelet activation; transfusion medicine procedures; risk factors in atherosclerosis; detection of cancer markers, and colour.
Dr. Horsewood was also a member of the clinical team at The Cleveland Clinic Foundation that discovered a strong correlation between elevated levels of Skin Cholesterol and abnormal treadmill stress-test results related to establishing risk for coronary artery disease (Clinical Chemistry 47, No. 7, 2001).
Dr. Horsewood is now a scientific and regulatory consultant to Miraculins, Inc. as well as an Assistant Professor at the Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University part-time).
Type your email address here:
I want email updates for:
Career Opportunitiesinvestor relationsmiraculins news
Sign Up Now